Some individuals may not qualify because: Their current Medicare coverage already provides medication through another benefit
Structural joint changes associated with arthritis remain present even when there are weight changes
On August 4, 2025, they filed 14 lawsuits in a single day against pharmacies and telehealth platforms
Diabetics with the greatest risk are the ones increasingly adopting GLP-1s
In particular, she notes people using GLP-1s tend to lose muscle first, but regain fat when they stop using the drug
Earlier studies suggest that semaglutide (sold as Ozempic, Wegovy, and Rybelsus) may cause more digestive issues, including diarrhea, than older GLP-1 medications like liraglutide (Saxenda and Victoza)